The Welland Tribune

Why we need a digital vaccinatio­n scar for the 21st century

- KUMANAN WILSON Kumanan Wilson is a physician at The Ottawa Hospital and a member of the University of Ottawa Centre for Health Law, Policy and Ethics.

In the 1800s, smallpox ravaged the world. Fortunatel­y, a vaccine had been developed that could protect individual­s. This vaccine left a scar at the site of injection and identified the individual­s as “immune.”

As we look toward the future of the COVID-19 pandemic, unless the virus burns out or an effective therapeuti­c interventi­on becomes available, the only way out of our current situation will be immunity — either natural or induced by a vaccine. If so, we will need to create a digital proof of immunity, a digital version of the smallpox scar, to help society to return to normal.

Ideally, a safe and effective vaccine will be available in the new year. If this is the case, we will need to have effective systems in place to identify those who are immunized. Our existing system of largely paper records will not be adequate.

Here is how such a system should work. Most provincial/territoria­l government­s have repositori­es of immunizati­on data. For the eventual COVID-19 vaccine, they will need to ensure that this data is accurate and that the individual identified did, indeed, receive the vaccine. The government could then issue a verified credential, an immunizati­on badge, which contains an easily scannable bar code or QR code, through government portals. This can be consumable by third party apps or be downloaded similar to a boarding pass.

To enter into certain venues, such as sporting events or for internatio­nal travel, the digital badge will have to be presented. The bar code will be scanned and matched to an individual’s ID card, just as we do for boarding passes. This will permit entry or travel. I expect our tolerance for philosophi­cal exemptions will be much lower given the consequenc­es on both health and the economy if outbreaks re-emerge.

Ideally an internatio­nal standard for this vaccinatio­n will be set under the Internatio­nal Health Regulation­s which already provide guidance for Yellow Fever vaccine certificat­es. This guidance needs to take into account the digitizati­on of these certificat­es.

More controvers­ial is the issuance of digital badges for natural immunity confirmed by antibody testing. The science and ethics of this solution are not mature at present, but that should not preclude us from considerin­g it.

As for immunizati­on, antibody data from credential­ed labs could be stored in immunity repositori­es and digital badges issued if a threshold of immunity is considered to be achieved. The most likely initial applicatio­n of this solution will be front-line workers where, if we are confident natural immunity provides protection, we can create systems ensuring certain percentage­s of workers are identified to be immune. This will create a “shield immunity” disrupting the transmissi­on of the virus and protecting front-line workers and those they care for.

A digital solution will have security and privacy risks that a paper record won’t have. However, a digital solution will be agile and adaptable in a way paper records cannot be. For example, if scientific evidence emerges on waning immunity, digital badges can be revoked. Decentrali­zed ledgers (think blockchain) can facilitate the movement of this informatio­n across borders and between institutio­ns.

As we enter into the next stage of this pandemic, we must start taking steps to ensure we have the right technology in place when science provides us with solutions. I have confidence that the combinatio­n of science and technology with ethical and legal oversight can accelerate our return to normal.

Newspapers in English

Newspapers from Canada